Astellas To Pay $3bn For Gene Therapy Company Audentes

Acquisition Includes Lead Asset AT132

San Francisco
Audentes is headquartered in San Francisco
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Focus On Asia

More from Scrip